End-Stage Renal Disease in African Americans With Lupus Nephritis Is Associated With APOL1

Autor: Niewold, Timothy B., Lim, S. Sam, Birmingham, Daniel J., Criswell, Lindsey A., Garner, Neva E., Hicks, Pamela J., Hebert, Lee A., Sivils, Kathy L., Reveille, John D., Williams, Adrienne H., Langefeld, Carl D., Petri, Michelle, Segal, Mark S., Harley, John B., Kamen, Diane L., Vinnikova, Anna K., Croker, Jennifer A., Salmon, Jane E., Byers, Joyce R., Brown, Elizabeth E., Edberg, Jeffrey C., Comeau, Mary E., Merrill, Joan T., Tsao, Betty P., Andringa, Kelly K., Gibson, Keisha L., Freedman, Barry I., Costenbader, Karen H., James, Judith A., Alarcón, Graciela S., Patel, Neha M., Ramsey-Goldman, Rosalind
Jazyk: angličtina
Rok vydání: 2014
Předmět:
DOI: 10.17615/yd3a-5a16
Popis: Lupus nephritis (LN) is a severe manifestation of systemic lupus erythematosus (SLE) that exhibits familial aggregation and may progress to end-stage renal disease (ESRD). LN is more prevalent among African Americans than among European Americans. This study was undertaken to investigate the hypothesis that the apolipoprotein L1 gene (APOL1) nephropathy risk alleles G1/G2, common in African Americans and rare in European Americans, contribute to the ethnic disparity in risk.
Databáze: OpenAIRE